These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 31191536)

  • 41. A coreceptor interaction between the CD28 and TNF receptor family members B and T lymphocyte attenuator and herpesvirus entry mediator.
    Gonzalez LC; Loyet KM; Calemine-Fenaux J; Chauhan V; Wranik B; Ouyang W; Eaton DL
    Proc Natl Acad Sci U S A; 2005 Jan; 102(4):1116-21. PubMed ID: 15647361
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Human Blood CD1c+ Dendritic Cells Encompass CD5high and CD5low Subsets That Differ Significantly in Phenotype, Gene Expression, and Functions.
    Yin X; Yu H; Jin X; Li J; Guo H; Shi Q; Yin Z; Xu Y; Wang X; Liu R; Wang S; Zhang L
    J Immunol; 2017 Feb; 198(4):1553-1564. PubMed ID: 28087664
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Disruption of the Notch pathway aggravates airway inflammation by inhibiting regulatory T cell differentiation via regulation of plasmacytoid dendritic cells.
    Qu SY; Ti XY; Zhang J; Wu CG
    Scand J Immunol; 2020 May; 91(5):e12865. PubMed ID: 32185817
    [TBL] [Abstract][Full Text] [Related]  

  • 44. CD5 instructs extrathymic regulatory T cell development in response to self and tolerizing antigens.
    Henderson JG; Opejin A; Jones A; Gross C; Hawiger D
    Immunity; 2015 Mar; 42(3):471-83. PubMed ID: 25786177
    [TBL] [Abstract][Full Text] [Related]  

  • 45. B and T lymphocyte attenuator regulates T cell activation through interaction with herpesvirus entry mediator.
    Sedy JR; Gavrieli M; Potter KG; Hurchla MA; Lindsley RC; Hildner K; Scheu S; Pfeffer K; Ware CF; Murphy TL; Murphy KM
    Nat Immunol; 2005 Jan; 6(1):90-8. PubMed ID: 15568026
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Detection of protein on BTLAlow cells and in vivo antibody-mediated down-modulation of BTLA on lymphoid and myeloid cells of C57BL/6 and BALB/c BTLA allelic variants.
    del Rio ML; Kaye J; Rodriguez-Barbosa JI
    Immunobiology; 2010 Jul; 215(7):570-8. PubMed ID: 19837478
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Interfering with coinhibitory molecules: BTLA/HVEM as new targets to enhance anti-tumor immunity.
    Pasero C; Olive D
    Immunol Lett; 2013 Mar; 151(1-2):71-5. PubMed ID: 23439006
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Increased Heterologous Protein Expression in Drosophila S2 Cells for Massive Production of Immune Ligands/Receptors and Structural Analysis of Human HVEM.
    Liu W; Vigdorovich V; Zhan C; Patskovsky Y; Bonanno JB; Nathenson SG; Almo SC
    Mol Biotechnol; 2015 Oct; 57(10):914-22. PubMed ID: 26202493
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Two phenotypically distinct subsets of spleen dendritic cells in rats exhibit different cytokine production and T cell stimulatory activity.
    Voisine C; Hubert FX; Trinité B; Heslan M; Josien R
    J Immunol; 2002 Sep; 169(5):2284-91. PubMed ID: 12193693
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cutting Edge: the BTLA-HVEM regulatory pathway interferes with protective immunity to intestinal Helminth infection.
    Breloer M; Hartmann W; Blankenhaus B; Eschbach ML; Pfeffer K; Jacobs T
    J Immunol; 2015 Feb; 194(4):1413-6. PubMed ID: 25595777
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Soluble B and T lymphocyte attenuator possesses antitumor effects and facilitates heat shock protein 70 vaccine-triggered antitumor immunity against a murine TC-1 cervical cancer model in vivo.
    Han L; Wang W; Fang Y; Feng Z; Liao S; Li W; Li Y; Li C; Maitituoheti M; Dong H; Lai Z; Gao Q; Xi L; Wu M; Wang D; Zhou J; Meng L; Wang S; Ma D
    J Immunol; 2009 Dec; 183(12):7842-50. PubMed ID: 19923459
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Amelioration of myocarditis by HVEM-overexpressing dendritic cells through induction of IL-10-producing cells.
    Cai G; Wang H; Qin Q; Zhang J; Zhu Z; Liu M; Shen Q
    Cardiovasc Res; 2009 Dec; 84(3):425-33. PubMed ID: 19570810
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Lung-resident mesenchymal stem cells regulated the inflammatory responses in innate and adaptive immune cells through HVEM-BTLA pathway during ARDS.
    Cheng T; Feng Y; Chen X; Zhou J; Song Y
    Exp Cell Res; 2020 Oct; 395(1):112155. PubMed ID: 32598875
    [TBL] [Abstract][Full Text] [Related]  

  • 54. B and T lymphocyte attenuator mediates inhibition of tumor-reactive CD8+ T cells in patients after allogeneic stem cell transplantation.
    Hobo W; Norde WJ; Schaap N; Fredrix H; Maas F; Schellens K; Falkenburg JH; Korman AJ; Olive D; van der Voort R; Dolstra H
    J Immunol; 2012 Jul; 189(1):39-49. PubMed ID: 22634623
    [TBL] [Abstract][Full Text] [Related]  

  • 55. CD5, an important regulator of lymphocyte selection and immune tolerance.
    Raman C
    Immunol Res; 2002; 26(1-3):255-63. PubMed ID: 12403363
    [TBL] [Abstract][Full Text] [Related]  

  • 56. BTLA and HVEM cross talk regulates inhibition and costimulation.
    Gavrieli M; Sedy J; Nelson CA; Murphy KM
    Adv Immunol; 2006; 92():157-85. PubMed ID: 17145304
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Herpes Simplex Virus 1 Latency and the Kinetics of Reactivation Are Regulated by a Complex Network of Interactions between the Herpesvirus Entry Mediator, Its Ligands (gD, BTLA, LIGHT, and CD160), and the Latency-Associated Transcript.
    Wang S; Ljubimov AV; Jin L; Pfeffer K; Kronenberg M; Ghiasi H
    J Virol; 2018 Dec; 92(24):. PubMed ID: 30282707
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Balancing co-stimulation and inhibition with BTLA and HVEM.
    Murphy KM; Nelson CA; Sedý JR
    Nat Rev Immunol; 2006 Sep; 6(9):671-81. PubMed ID: 16932752
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Regulation of inflammation, autoimmunity, and infection immunity by HVEM-BTLA signaling.
    Shui JW; Steinberg MW; Kronenberg M
    J Leukoc Biol; 2011 Apr; 89(4):517-23. PubMed ID: 21106644
    [TBL] [Abstract][Full Text] [Related]  

  • 60. High expression of the inhibitory receptor BTLA in T-follicular helper cells and in B-cell small lymphocytic lymphoma/chronic lymphocytic leukemia.
    M'Hidi H; Thibult ML; Chetaille B; Rey F; Bouadallah R; Nicollas R; Olive D; Xerri L
    Am J Clin Pathol; 2009 Oct; 132(4):589-96. PubMed ID: 19762537
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.